Jim Breyer@jimihendrixlive · 2026/08/23观点输出@BenLamm @MollySOShea 🙏 So proud to be an initial investor @colossal
AI:延续个人公开立场,强调长期主义、执行效率与行业方向判断。
Jim Breyer@jimihendrixlive · 2026/08/23观点输出@MollySOShea 🙏
AI:延续个人公开立场,强调长期主义、执行效率与行业方向判断。
Jim Breyer@jimihendrixlive · 2026/08/21观点输出@SaraEisen Well done!
AI:延续个人公开立场,强调长期主义、执行效率与行业方向判断。
Jim Breyer@jimihendrixlive · 2026/08/20观点输出Proud seed investor @colossal
AI:延续个人公开立场,强调长期主义、执行效率与行业方向判断。
Jim Breyer@jimihendrixlive · 2026/08/19观点输出@BillAckman ❤️🙏
AI:延续个人公开立场,强调长期主义、执行效率与行业方向判断。
Jim Breyer@jimihendrixlive · 2026/08/19观点输出@BillAckman Bill, Wonderful!
AI:延续个人公开立场,强调长期主义、执行效率与行业方向判断。
Jim Breyer@jimihendrixlive · 2026/08/19观点输出https://t.co/XxuCGsR2IS
AI:延续个人公开立场,强调长期主义、执行效率与行业方向判断。
Jim Breyer@jimihendrixlive · 2026/08/19赛道影响At Breyer Capital, we look for platform technologies that collapse the distance between fundamental discovery and real clinical impact.
Today, most biomedical AI remains constrained by fragmented datasets and single-institution cohorts that learn site-specific artifacts rather than durable biology. To move medicine from describing syndromes to understanding mechanisms, we have to start with the data layer.
NetworkBio announced $50M today to build that foundation. Breyer Capital led the first institutional round and has invested in every round since.
Our thesis on why Network Bio represents an irreproducible advantage in biomedical AI:
- Aggregating Multimodal Ground Truth: By creating the United States Biobank across top medical centers, Network links tissue, blood, molecular profiles, and longitudinal EHR outcomes across 500K+ patients.
- The "Virtual Biopsy" Platform: Tissue reveals the disease microenvironment; blood provides accessible scale. Using cfRNA foundation models built with @nvidia, Network Bio is mapping local tissue biology into scalable, non-invasive liquid biomarkers.
- Immediate Translational Velocity: Validated by peer-reviewed oncology detection data and a $30M + co-development partnership with a Fortune 100 healthcare leader, Network is committed to bending the arc of medicine towards molecular characterization and precision.
Proud to back the Network Bio team as they build the backbone for mechanistic understanding of human disease.
Jim Breyer@jimihendrixlive · 2026/08/19赛道影响We are so excited. Well said @morgancheatham
AI:偏主题投资表达,释放对基础设施与新叙事的偏多信号。
Jim Breyer@jimihendrixlive · 2026/08/18观点输出@shak @Neko Love this!
AI:延续个人公开立场,强调长期主义、执行效率与行业方向判断。
评论
暂无评论